C-Met-IN-19
Product Specifications
Target
C-Met/HGFR
Related Pathways
Tyrosine Kinase/Adaptors
Bioactivity
C-Met-IN-19 (Compound 21j) is a potent c-Met inhibitor with an IC50 of 1.99 nM, demonstrating cytotoxic effects on various cancer cell lines, including A549, HT-29, SGC-7901, and MDA-MB-231, with IC50 values of 0.25, 0.36, 0.98, and 0.76 ?M, respectively [1].
Molecular Formula
C34H37Cl2FN4O7S
Molecular Weight
735.65
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15083643 1 Vial
Lentiviral human DAAM1 shRNA (UAS) - Lentiviral human DAAM1 shRNA (UAS, iRFP) (100)
Ask
View Details 
MBS6492292-01 0.1 mL
Pax 2, Phosphorylated (Paired Box Gene 2, Paired Box Homeotic Gene 2, Paired Box Protein 2, Paired Box Protein Pax-2, Paired Box Protein Pax2, Pax-2) (AP)
Ask
View Details MBS6492292-02 5x 0.1 mL
Pax 2, Phosphorylated (Paired Box Gene 2, Paired Box Homeotic Gene 2, Paired Box Protein 2, Paired Box Protein Pax-2, Paired Box Protein Pax2, Pax-2) (AP)
Ask
View Details